Roupen Odabashian, Hematology/Oncology Fellow at Karmanos Cancer Institute, and Podcast Host at OncoDaily, shared a post on LinkedIn:
“Everyone’s building AI for doctors. Almost nobody’s building for patients.
And it makes perfect sense when you follow the money.
Hospitals pay for AI that saves them time and money. Payers pay for AI that reduces their costs. VCs fund what hospitals and payers will buy.
Patients? They don’t control the budget.
So we get:
AI scribes that save doctors 2 hours/day (hospitals pay)
AI that reduces unnecessary imaging (payers pay)
AI that automates prior auth (everyone pays)
What we don’t get:
AI that helps patients understand their diagnosis in plain language
AI that reminds patients why they need that medication (in ways they’ll actually follow)
AI that connects patients to resources when they can’t afford treatment
The brutal truth: Healthcare AI follows the checkbook, not the patient need.
The payment model determines the innovation. When hospitals buy the software, we optimize for clinical workflows. When payers buy it, we optimize for cost reduction.
Patients aren’t in the room when purchase decisions are made!”
More posts featuring Roupen Odabashian.